Wednesday, July 8, 2026

pharma · Multiple Sclerosis · Relapsing Remitting Multiple Sclerosis · CTNM

Contineum Therapeutics

Contineum Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.

San Diego, USA HQ
2017 Founded
59 Employees
Public company Type
CTNM · NYSE Ticker
Company details
Status
Public
HQ
San Diego, USA
Founded
2017
Employees
59
Programs
7
Drugs
3
Patents
2
Intelligence · Clinical Trials

Contineum Therapeutics clinical trials

Registry index of 8 ClinicalTrials.gov studies linked to Contineum Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Contineum Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

7 updates

Latest clinical program signals indexed for Contineum Therapeutics.

  1. PIPE-791 Dose A — Phase 2

    Clinical update
  2. PIPE-505 — Phase 2

    Clinical update
  3. PIPE-307 Dose A — Phase 2

    Clinical update
  4. PIPE-307 — Phase 1

    Clinical update
  5. PIPE-791 — Phase 1

    Clinical update
  6. PIPE-791 — Phase 1

    Clinical update
  7. PIPE-791 — Phase 1

    Clinical update

Trial registry

8 studies